Skip to main content

Table 3 Left ventricular ejection fraction before CTO-PCI and during follow-up

From: Impact of coronary collateralization on long-term clinical outcomes in type 2 diabetic patients after successful recanalization of chronic total occlusion

Variable

All patients (n = 533)

Non-diabetes (n = 335) (63%)

Diabetes (n = 198) (37%)

p value (non-T2DM vs T2DM)

All

Good CC (n = 237)

Poor CC (n = 98)

p value

All

Good CC (n = 118)

Poor CC (n = 80)

p value

LVEF (%) at baseline

52.39 ± 7.38

53.00 ± 7.27

53.52 ± 6.81

51.74 ± 8.18

0.042

51.36 ± 7.46

51.70 ± 7.48

50.85 ± 7.44

0.431

0.013

LVEF (%) at follow-up

54.89 ± 6.54

55.72 ± 6.18

56.62 ± 5.73

53.54 ± 6.71

< 0.001

53.49 ± 6.89

54.17 ± 6.56

52.50 ± 7.29

0.095

< 0.001

ΔLVEF (%)

2.50 ± 4.63

2.72 ± 4.82

3.10 ± 4.75

1.80 ± 4.87

0.024

2.14 ± 4.29

2.47 ± 4.22

1.65 ± 4.37

0.19

0.163

p value (baseline vs follow-up)

< 0.001

< 0.001

< 0.001

< 0.001

 

< 0.001

< 0.001

< 0.001

  
  1. T2DM type 2 diabetes mellitus, CC coronary collateralization, CTO chronic total occlusion, PCI percutaneous coronary intervention, LVEF left ventricular ejection fraction, ΔLVEF change in eft ventricular ejection fraction
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840